Position in NBIX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$506,968
+$139,150 QoQ
Shares Held
3,008
+7.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#470
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $6,951,552 across 44 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
143,876 | $4,874,518 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,544 | $836,585 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
3,008 | $506,968 | |
| 4 | ZTS |
Zoetis Inc.
|
2,994 | $215,148 | |
| 5 | LQDA |
Liquidia Corp
|
950 | $75,743 | |
| 6 | CTOR |
Citius Oncology, Inc.
|
107,424 | $69,825 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
447 | $49,590 | |
| 8 | VTRS |
Viatris Inc
|
2,398 | $38,080 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $506,968 | 3,008 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $367,818 | 2,792 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $408,612 | 2,881 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $347,440 | 2,475 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $272,998 | 2,172 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $230,490 | 2,084 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $275,730 | 2,020 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $216,959 | 1,883 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $284,563 | 2,067 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $345,765 | 2,507 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $270,371 | 2,052 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $203,737 | 1,811 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $169,268 | 1,795 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $187,965 | 1,857 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $196 | 1,946 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $242,689 | 2,285 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $167,470 | 1,718 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $140,343 | 1,497 | Shares | Sole | 2022-08-08 | |
| 2021-12-31 | $126,307 | 1,483 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $141,083 | 1,471 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $147,342 | 1,514 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $158,031 | 1,625 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $137,065 | 1,430 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $97,121 | 1,010 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $14,640 | 120 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $9,520 | 110 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||